Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation

With post-transplantation cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis, nonmyeloablative HLA-haploidentical (NMA haplo) and HLA-matched blood or marrow transplantation (BMT) have comparable outcomes. Early discontinuation of immunosuppression may reduce the risk of relapse...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Kasamon, Yvette L., Fuchs, Ephraim J., Zahurak, Marianna, Rosner, Gary L., Symons, Heather J., Gladstone, Douglas E., Huff, Carol Ann, Swinnen, Lode J., Brodsky, Robert A., Matsui, William H., Borrello, Ivan, Shanbhag, Satish, Cooke, Kenneth R., Ambinder, Richard F., Luznik, Leo, Bolaños-Meade, Javier, Jones, Richard J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5977987/
https://ncbi.nlm.nih.gov/pubmed/29353109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.01.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados